Tiziana Life Sciences Ltd Operating Expense
Tiziana Life Sciences Ltd (TLSA) reported Operating Expense of $15.79 million for the 12-month period ending 2024-12-31, per its 20-F/A filed 2025-05-08.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:OperatingExpense · last filed 2025-05-08
| Period end | Operating Expense 12 month |
|---|---|
| 2024-12-31 | $15.79M 20-F/A · filed 2025-05-08 |
| 2023-12-31 | $17.98M 20-F/A · filed 2025-05-08 |
| 2022-12-31 | $14.59M 20-F/A · filed 2025-05-08 |
| 2021-12-31 | $27.37M 20-F · filed 2024-05-10 |
| 2018-12-31 | $9.93M 20-F · filed 2019-04-04 |
| 2017-12-31 | $10.62M 20-F · filed 2019-04-04 |
| 2016-12-31 | $9.88M 20-F · filed 2019-04-04 |